• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

A89:GR

28.297 EUR 0.443 1.54%

As of 11:08:02 ET on 11/21/2014.

Snapshot for Adocia (A89)

Open: 28.954 Day's Range: 28.297 - 29.169 Volume: 0
Previous Close: 28.740 52wk Range: 5.290 - 39.500 1-Yr Rtn: +408.03%

Stock Chart for A89

No chart data available.
  • A89:GR 28.297
  • 1D
  • 1M
  • 1Y
28.740
Interactive A89 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for A89

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -1.5650
Est. PEG Ratio -
Market Cap (M EUR) 175.82
Shares Outstanding (M) 6.21
30 Day Average Volume 17
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for A89

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for A89

Adocia SAS is a biotechnology company. The Company researches and develops protein delivery products for wound healing and tissue regeneration based on growth factors. Adocia is specialized in insulin therapy and the treatment of the diabetic foot ulcer, one of the main complications of diabetes.

Gerard SoulaChairman/CEOValerie DanaguezianChief Financial Officer
Olivier SoulaDir:R&D/Deputy Gen MgrRemi SoulaDir:Business Development
More Company Profile & Key Executives for A89

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil